Shanqiang Qu

Guangzhou Dadao Bei Street
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Clinical, surgical, and molecular characteristics and outcomes of adult patients with diffuse midline glioma, H3 K27-altered, treated with surgical resection.

Clinical, surgical, and molecular characteristics and outcomes of adult patients with diffuse midline glioma, H3 K27-altered, treated with surgical resection.

Journal: Journal of neuro-oncology

Published: May 17, 2026

Contemporary Precision Stratification and Prognostic Features of Primary Gliomas in a Southern Chinese Population.

Contemporary Precision Stratification and Prognostic Features of Primary Gliomas in a Southern Chinese Population.

Journal: Research (Washington, D.C.)

Published: July 19, 2025

Redefining Treatment Paradigms for Glioma in Adolescents and Young Adults: Population-Based Evidence for Molecular Classification.

Redefining Treatment Paradigms for Glioma in Adolescents and Young Adults: Population-Based Evidence for Molecular Classification.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 04, 2025

Disrupting the SHOC2-RAS Nexus: a new frontier in targeting RAS-Driven cancers.

Disrupting the SHOC2-RAS Nexus: a new frontier in targeting RAS-Driven cancers.

Journal: Molecular biomedicine

Published: June 18, 2025

Integrating Single-Cell and Spatial Transcriptomics Reveals NK Cell Subpopulations Associated With Immunotherapy for Melanoma.

Integrating Single-Cell and Spatial Transcriptomics Reveals NK Cell Subpopulations Associated With Immunotherapy for Melanoma.

Journal: Smart medicine

Published: May 06, 2025

The HBP Pathway Inhibitor FR054 Enhances Temozolomide Sensitivity in Glioblastoma Cells by Promoting Ferroptosis and Inhibiting O-GlcNAcylation.

The HBP Pathway Inhibitor FR054 Enhances Temozolomide Sensitivity in Glioblastoma Cells by Promoting Ferroptosis and Inhibiting O-GlcNAcylation.

Journal: CNS neuroscience & therapeutics

Published: April 28, 2025

Anlotinib may have a therapeutic effect on papillary craniopharyngiomas without the BRAFv600e mutation.

Anlotinib may have a therapeutic effect on papillary craniopharyngiomas without the BRAFv600e mutation.

Journal: Acta neuropathologica communications

Published: December 27, 2024

Targeting ferroptosis in cancer stem cells: A novel strategy to improve cancer treatment.

Targeting ferroptosis in cancer stem cells: A novel strategy to improve cancer treatment.

Journal: Genes & diseases

Published: April 18, 2024

A ROS-Responsive Lipid Nanoparticles Release Multifunctional Hydrogel Based on Microenvironment Regulation Promotes Infected Diabetic Wound Healing.

A ROS-Responsive Lipid Nanoparticles Release Multifunctional Hydrogel Based on Microenvironment Regulation Promotes Infected Diabetic Wound Healing.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: March 28, 2024

Correction: albumin-bound paclitaxel augment temozolomide treatment sensitivity of glioblastoma cells by disrupting DNA damage repair and promoting ferroptosis.

Correction: albumin-bound paclitaxel augment temozolomide treatment sensitivity of glioblastoma cells by disrupting DNA damage repair and promoting ferroptosis.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 24, 2023

Albumin-bound paclitaxel augment temozolomide treatment sensitivity of glioblastoma cells by disrupting DNA damage repair and promoting ferroptosis.

Albumin-bound paclitaxel augment temozolomide treatment sensitivity of glioblastoma cells by disrupting DNA damage repair and promoting ferroptosis.

Journal: Journal of experimental & clinical cancer research : CR

Published: July 06, 2023

A novel mechanism of ferroptosis surveillance offers promising therapeutic avenues for breast and prostate cancers.

A novel mechanism of ferroptosis surveillance offers promising therapeutic avenues for breast and prostate cancers.

Journal: Molecular biomedicine

Published: June 18, 2023

Showing 1-12 of 30

Last Updated: 09/26/2026